Abstract: Small molecules drug and therapeutic proteins differ substantially in many of their class attributes. At the root of this are their different physiochemical properties, which affect not only the pharmacological aspects of the drug (e.g., mechanism of action, pharmacodynamics(PD), pharmacokinetics(PK),but also safety and efficacy, and even impact product manufacturing/ quality considerations,.Summary: Biopharmaceuticals are protein with considerable therapeutic structural diversity. They tend to be between 100 to 1000 times larger than traditional small molecule drug. Such complex proteins can't be produced using conventional chemical synthesis rather than in a living cell under stringently controlled condition .References: https://www.stabicon.com/blog/
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Unified approach for in vitro data based parameters estimation
Veronika Musatova, Oleg Demin, Svetlana Rubina
Business Development Team
Liquids Dosage Forms Development
Moisture Content Determination
Genome Editing in Plant